Vidacare(R) Announces Lithium Battery-Powered EZ-IO(R) Power Driver; New Driver Significantly Lengthens Shelf Life, Improves Control and User Experience

SAN ANTONIO--(BUSINESS WIRE)--March 27, 2006--Vidacare(R), manufacturer of the EZ-IO(R) product system, the leading solution for immediate vascular access when conventional IV access is challenging or impossible, today announced the addition of an improved lithium-powered driver to replace the alkaline battery-powered drivers used with the EZ-IO product system.

The new EZ-IO Power Driver addresses the single biggest concern associated with using a battery-operated device in an emergency situation: the condition and reliability of the batteries. By using a lithium ion power supply, emergency personnel can complete 500 to 750 EZ-IO insertions--more than 10 times the insertions they could make using alkaline batteries. Additional attributes of the lithium battery upgrade include an increased shelf life to 15 years, a 10 percent increase in torque over alkaline batteries, decreased battery weight and elimination of the linear decline in battery performance associated with alkaline batteries. Vidacare anticipates that the user should not have to change the lithium batteries over the life of the product, thereby making it a hassle-free battery-powered device.

“The addition of a lithium battery to the EZ-IO Power Driver is an ideal example of our ability to respond to the users' needs while improving upon our technologically-advanced design in order to elevate the capabilities of our product and enhance user experience.”

"At Vidacare we are dedicated to continuously improving and advancing our intraosseous medical device products," said Phil Faris, Jr., Vidacare's CEO and president. "The addition of a lithium battery to the EZ-IO Power Driver is an ideal example of our ability to respond to the users' needs while improving upon our technologically-advanced design in order to elevate the capabilities of our product and enhance user experience."

About Vidacare

Since acquiring their innovative intraosseous technology from the University of Texas, Vidacare has orchestrated an exceptional effort to bring intraosseous infusion to the medical community to provide safe, fast and secure access in emergency medical situations and during routine clinical care. Vidacare is a leader in educating and providing the medical community with the means to use intraosseous space or bone marrow as a non-collapsible vein, through which emergency health professionals are better able to quickly administer life saving drugs and fluids and physicians are able to administer medicines or obtain samples. These systems offer the potential to establish new standards of clinical excellence in the safe, rapid institution of life-saving medical therapies. Headquartered in San Antonio, TX, the company was established in 2001. For more information visit www.vidacare.com.

Contacts

Townsend Inc. for Vidacare Corporation
Alan Edwards/Tanya Orth, 1-858-457-4888
aedwards@townsendinc.com
torth@townsendinc.com

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.